Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CME Medical is a medical device company best known for ambulatory infusion and syringe pump systems used across hospital, homecare, palliative care, pain management, and nutrition settings. The business originated as Caesarea Medical Electronics, an Israeli infusion pump manufacturer, and its U.K. operation was historically known as CME Medical UK. BD completed its acquisition of Caesarea Medical Electronics in April 2017, and the U.K. entity was later renamed Becton Dickinson (CME) U.K. while continuing to support the installed base of CME-branded products. Its core products have included the T34 ambulatory syringe pump, BodyGuard infusion pump systems, and related administration sets and accessories. The company is therefore healthcare-related, but it is not a biotech or drug-development company; it is a commercial-stage medtech business focused on infusion delivery devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CME Medical.